Skip to main content
Caplight Logo









BellaSeno

BellaSeno

Private
LeipzigHealthcare & Life Scienceshttps://www.bellaseno.com/

Last Round

Grant

Jun 5, 2024

Total Funding Raised

$3.53M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

BellaSeno is a medtech company that develops and manufactures resorbable soft tissue and bone reconstruction implants using additive manufacturing.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, 3D Printing, Biotechnology, Clinical Trials, Smart Manufacturing

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

resorbable scaffolds3D printed implantstissue engineeringabsorbable implantsbreast reconstructionregenerative medicineadditive manufacturingsoft tissue reconstructionmedical device CMObone reconstructionPCL implantspectus excavatumbioresorbable polymerISO 13485clinical stage medtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BellaSeno Comparables

Compare BellaSeno with similar companies based on industry and business-model similarity.

BellaSeno comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Lattice Medical
93%
Tensive
86%
Healshape
86%

BellaSeno Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 5, 2024
GrantSep 15, 2021
GrantMar 10, 2021
Series BJul 15, 2019
Series AJan 1, 2018

Key People

Founding team and executive leadership

Thomas Lingner

Chief Technology Officer

Executive Team

BellaSeno Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 16, 2026

    Monthly visitors grew 349% MoM, reaching 557.

  • May 4, 2025

    Monthly visitors grew 148% MoM, from 644 to 1.6K.

BellaSeno Filings

Explore SEC and related filing metadata, where available.

BellaSeno filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about BellaSeno's valuation, stock price, and market status.

Is BellaSeno a public or private company?

BellaSeno is a private company.

What is the current stock price of BellaSeno?

BellaSeno is a private company with no public stock price. No recent secondary market data is available.

How much is BellaSeno worth (valuation)?

Valuation information for BellaSeno is not publicly available.

Can I buy BellaSeno stock?

BellaSeno shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was BellaSeno's last funding round?

BellaSeno's most recent funding round was Grant on June 5, 2024.

Who are the main investors in BellaSeno?

Key investors in BellaSeno include Queensland Government's Industry Partnership Program, Federal Ministry of Education and Research, Global Innovation Linkages Program.

Will BellaSeno IPO soon?

No public IPO plans have been announced for BellaSeno.

How can I track BellaSeno secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BellaSeno's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLeipzig
Employee Range17
Year Founded2015
Last FundingJun 5, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?